Benefits and concerns of simplification strategies in HIV-infected patients.
about
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and IntegraseSingle genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapyAdherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literatureReuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.Simplification strategies to reduce antiretroviral drug exposure: progress and prospects.A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infection.Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy.Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial.Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.Lopinavir/ritonavir monotherapy as maintenance treatment in HIV-infected individuals with virological suppression: results from a pilot study in Brazil.Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART.Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen.Cost-effectiveness analysis of enfuvirtide (ENF) added to an optimized therapy compared with an optimized therapy in patients with HIV/AIDS.
P2860
Q34372481-81C18761-852E-463C-B960-8308316E1E13Q34762297-A2FA8626-1BAE-46F5-B58A-26B78EAC78A3Q34779869-73667A6C-7B02-475A-8F4C-6DB0BDF4C8CBQ35158051-000D0C35-056D-46D7-9599-14FF639D5DA4Q35959075-A945CEB7-0B3D-4420-8D71-34E62093AC2FQ35965722-020792FF-AAF2-4D4C-A157-181CD37C51A9Q37277829-66C8FD71-4661-4825-9B8D-FC2CF3597FC3Q37823555-7EC1AF44-01CB-4274-AB57-FDCFDABF13C0Q38410752-D2422786-9324-4D9E-B10B-716D226EE632Q42772425-E103B2A3-0576-4683-9C31-3D0366A01092Q42772430-C775C302-508D-4516-9BDA-0750AC695731Q42772433-B8228D0A-E641-4C2E-ADF4-A5519CA7AFF2Q42772436-79023B99-B4D4-4609-A85E-4A53249E714CQ42772440-5D7429D6-188A-45C6-B375-384DAAB67B65Q46709465-4959BEF1-D7E4-4731-90E4-713CB942858BQ46935128-454B02E5-43AB-42C6-944F-1D53E0DCE4DDQ46935140-11A6C094-2FCA-4F16-9577-163EEA3DC8F4Q50668371-173F49F4-A931-403D-AEDA-243D9994F674
P2860
Benefits and concerns of simplification strategies in HIV-infected patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Benefits and concerns of simplification strategies in HIV-infected patients.
@ast
Benefits and concerns of simplification strategies in HIV-infected patients.
@en
type
label
Benefits and concerns of simplification strategies in HIV-infected patients.
@ast
Benefits and concerns of simplification strategies in HIV-infected patients.
@en
prefLabel
Benefits and concerns of simplification strategies in HIV-infected patients.
@ast
Benefits and concerns of simplification strategies in HIV-infected patients.
@en
P356
P1476
Benefits and concerns of simplification strategies in HIV-infected patients.
@en
P2093
Anna Bonjoch
Eugènia Negredo
P304
P356
10.1093/JAC/DKL191
P407
P577
2006-06-27T00:00:00Z